Boston Family Office LLC Enanta Pharmaceuticals Inc Transaction History

Boston Family Office LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$38.13 - $76.93 $108,670 - $219,250	-2,850 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$60.19 - $97.37 $171,541 - $277,504	2,850 New	2,850 $213,000
Q3 2019 Nov 12, 2019	SELL	$60.08 - $88.17 $165,220 - $242,467	-2,750 Closed	0 $0
Q1 2019 May 09, 2019	BUY	$69.08 - $105.66 $189,970 - $290,565	2,750 New	2,750 $263,000
Q4 2018 Feb 12, 2019	SELL	$65.41 - $84.65 $179,877 - $232,787	-2,750 Closed	0 $0
Q1 2018 Apr 30, 2018	BUY	$57.91 - $92.15 $159,252 - $253,412	2,750 New	2,750 $223,000

110

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $178M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Boston Family Office LLC, based on Form 13F filings with the SEC.

Stay updated on Boston Family Office LLC with notifications on news.